DNA X, Inc. filings document the company's shift from Sonim Technologies to a cryptocurrency trading-services business, including the acquisition of DNA X LLC, the completed sale of mobile device assets, and the January 2026 corporate rebrand while the Nasdaq ticker remained SONM.
The filing record includes Current Reports on Form 8-K and related amendments covering material agreements, convertible-note financing, common-stock issuance, operating results, shareholder voting matters, executive departures and compensation arrangements, and auditor changes. Other disclosures address late annual-report notification, internal-control weakness, going-concern language, capital structure, risk factors, and financial-reporting obligations.
On 30 June 2025, a Form 4 was filed reporting insider activity at Sonim Technologies (SONM). The filing shows that Laurence W. Lytton —identified as a 10 % owner (and indicated as a director) —sold his entire direct position in two open-market transactions coded “S.”
- 26 Jun 2025: 466,402 shares sold at a weighted-average price of $1.50 (price range $1.28-$1.75), leaving 400,514 shares directly held.
- 30 Jun 2025: 400,514 shares sold at a weighted-average price of $1.39 (price range $1.30-$1.47), reducing direct ownership to 0 shares.
In total, 866,916 shares were disposed of during the four-day window.
Lytton continues to have indirect exposure to 800,000 shares held by the Lytton-Kambara Foundation. He disclaims beneficial ownership of those shares except to the extent of his pecuniary interest.
No derivative securities were involved, and no purchases were reported. The complete exit from a direct holding by a 10 % owner is often viewed by investors as a potentially bearish signal, although the remaining foundation stake maintains some alignment of interests.
Sonim Technologies (NASDAQ: SONM) filed DEFA14A additional proxy materials revealing an unsolicited, non-binding proposal from Orbic North America to purchase substantially all operating assets for $25 million.
A Board-appointed Special Committee will evaluate the bid with legal and financial advisers. The 26 June 2025 offer expressly permits Sonim to proceed with its previously disclosed reverse take-over (RTO) letter of intent involving a private Nvidia-based HPC company. No shareholder action is required now; further updates will be provided.
Sonim Technologies (NASDAQ:SONM) filed a routine Definitive Additional Proxy Solicitation (DEFA14A) on June 27, 2025. The document contains only standard Schedule 14A cover information, confirms that no filing fee is required, and does not introduce new proposals, compensation changes, or other material disclosures. Accordingly, there is no substantive information likely to affect shareholder value or voting decisions.
Sonim Technologies (NASDAQ:SONM) filed DEFA14A additional proxy materials on June 26 2025. The document reproduces CFO Clay Crolius’s email to employees explaining how to obtain and vote the WHITE proxy card for the 2025 Annual Meeting. Voting closes July 17 2025 at 11:59 p.m. ET; questions are directed to proxy solicitor Sodali or individual brokers. Stockholders are encouraged to review the definitive proxy statement filed June 18 2025, which identifies directors and officers—Peter Liu, Clay Crolius, James Cassano, Mike Mulica, Jack Steenstra and Jeffrey Wang—as participants in the solicitation under SEC rules.
A significant Schedule 13D/A filing for Sonim Technologies reveals multiple reporting persons collectively holding a 19.04% stake in the company. The key reporting entities include:
- AJP Holding Company LLC - Beneficially owns 1,946,345 shares
- Jeffrey Wang (AJP's sole manager) - Controls 1,972,124 shares including 25,779 direct shares from RSUs
- Orbic North America LLC - Has shared control over holdings
- Ashima Narula (Orbic's manager) and Parveen Narula (Orbic's CEO) - Each controlling 1,947,345 shares
The filing indicates Orbic is pursuing a proposal to be funded through cash on hand and financing from Capstone Project Finance LLC. The ownership calculation is based on 10,338,905 outstanding shares reported in Sonim's recent proxy statement. This represents Amendment No. 12 to the original Schedule 13D, reflecting ongoing changes in the group's investment position.